Acute lymphoblastic leukaemia - first line - dasatinib initial PBS authority application form (PB271)

Use this form to apply for initial PBS-subsidised dasatinib for first line treatment of acute lymphoblastic leukaemia.

Page last updated: 17 November 2022.
QC 51325